🇺🇸 FDA
Patent

US 11459385

Anti-IL-2 antibodies and compositions and uses thereof

granted A61KA61K2039/505A61P

Quick answer

US patent 11459385 (Anti-IL-2 antibodies and compositions and uses thereof) held by The Regents of the University of California expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61P, A61P29/00, A61P3/10